To March 2023, we worked with primary care to increase the use of a number of asthma related medications and diagnostics as part of the Rapid Uptake Products (RUP) programme. These include biologics for treating severe asthma (Reslizumab, Benralizumab, Mepolizumab and Omalizumab) and measuring fractional exhaled nitric oxide (FeNO) concentration in asthma (NIOX VERO and NObreath).
Digital CHAMP COPD
During 2022, we worked with the health system in Bristol, North Somerset and South Gloucestershire (BNSSG) to roll-out the myCOPD app to support patients with chronic obstructive pulmonary disease (COPD). The myCOPD app provides guides on self-management, how and when to take medication and pulmonary rehabilitation to help patients to recover and manage their condition effectively at home.
Using Proactive Care Frameworks
We supported the piloting of a package of tools and resources designed by UCL Partners to enable primary care teams to continue to effectively manage patients with long term conditions during and post-COVID-19.
Frameworks focus on the management of Atrial Fibrillation; high blood pressure; high cholesterol; type 2 diabetes; asthma and COPD.